What is Semble?
Semble Technology operates at the intersection of clinical efficiency and administrative optimization. The company provides a robust software ecosystem designed to streamline the complexities of modern healthcare delivery. By focusing on the integration of medical and administrative tasks, Semble enables clinical teams to reduce operational friction, thereby enhancing the quality of patient care. Its platform serves as a critical infrastructure layer for healthcare providers, facilitating seamless data exchange and improving interoperability across fragmented medical systems. As the industry shifts toward more digitized, patient-centric models, Semble's market position as an enabler of operational excellence becomes increasingly vital.
How much funding has Semble raised?
Semble has raised a total of $58.5M across 3 funding rounds:
Seed
$3.2M
Series B
$15M
Series C
$40.3M
Seed (2019): $3.2M, investors not publicly disclosed
Series B (2024): $15M led by Octopus Ventures and Triple Point
Series C (2026): $40.3M supported by Revaia, Mercia Asset Management, Partech International, and Octopus Ventures
Key Investors in Semble
Revaia
Revaia is a growth equity investment fund based in Paris that champions sustainable leaders in the field of technology and innovation.
Mercia Asset Management
Mercia Asset Management provides equity and debt financing to UK businesses, acting as investment partners from scale-up to exit.
Partech International
Partech is a global investment firm that brings together capital, operational experience, and strategic support for entrepreneurs at seed, venture, and growth stages.
What's next for Semble?
With the successful closure of this major enterprise-level funding round, Semble is poised to enter a phase of aggressive scaling and product innovation. The strategic capital will likely be deployed to enhance the platform's core interoperability features and expand its footprint in international markets. Given the involvement of growth-focused investors, the company is expected to prioritize the development of advanced data analytics tools that empower clinical teams to make informed, real-time decisions. As Semble continues to redefine the standards of healthcare administration, the focus will remain on maintaining its competitive edge through technological differentiation and long-term value creation for its stakeholders.
See full Semble company page
